Skip to content
Screener

Compass Therapeutics, Inc. CMPX Q3 2025 earnings

Reported November 5, 2025 · Before market open

EPS-$0.08Beat by $0.06
EPS estimate-$0.14

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$229.3K
EPS estimate-$0.12

FAQ

When did Compass Therapeutics, Inc. report Q3 2025 earnings?
Compass Therapeutics, Inc. (CMPX) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Compass Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Compass Therapeutics, Inc. reported eps of $-0.08 for Q3 2025.
Did Compass Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.14 by $0.06.
How did Compass Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.08.
Where can I find Compass Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-007004) and the 10-Q periodic report (0001171843-25-007005) directly on SEC EDGAR. The filing index links above go to sec.gov.